Arcturus Therapeutics Holdings Inc. 8-K

What Happened
On March 3, 2026, Arcturus Therapeutics Holdings, Inc. announced and furnished a press release (Exhibit 99.1) reporting the company’s financial results for the quarter and year ended December 31, 2025 and providing a corporate update. The announcement was reported on Form 8‑K under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Date of filing/press release: March 3, 2026.
• Period covered: quarter and year ended December 31, 2025.
• Press release furnished as Exhibit 99.1 to the Form 8‑K.
• Form 8‑K also lists Exhibit 104 (Cover Page in Inline XBRL) under Item 9.01.

Why It Matters
This 8‑K delivers Arcturus’s most recent quarterly and full‑year financial performance and a corporate update, information investors use to assess revenue, expenses, cash position and near‑term prospects. Retail investors should read the furnished press release for the specific financial figures and any management commentary, and watch for the company’s 10‑K, earnings call or additional SEC filings for audited results and further detail.